Home›Stock Screener›Advanced Enzyme Tech

Advanced Enzyme Tech Share Price Today | Stock Price & Advanced Enzyme Tech Share Screener

ADVENZYMES Biotechnology
Live Share Price NSE
₹272.40
▼ -1.85 (-0.67%)
2026-10-05 00:00:00
Live Share Price BSE
₹272.75
▼ -1.65 (-0.60%)
2026-10-05 00:00:00

As of October 5, 2026, the live Advanced Enzyme Tech share price (NSE: ADVENZYMES) is ₹272.40 on NSE and ₹272.75 on BSE, down 0.67% from the previous close, with shares trading between ₹270.45 and ₹276.25 in today's trading session, and a 52-week range of ₹255.30–₹392.10. Check ADVENZYMES 52-week performance for the annual price range and momentum. Use the Advanced Enzyme Tech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Advanced Enzyme Tech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹211 and net income of ₹45, with EBITDA of ₹71, an operating margin of 31.0% and a profit margin of 21.3%.

Advanced Enzyme Tech Market Cap ₹3,139.81 Cr.
ADVENZYMES P/E Ratio (TTM) 18.50
Advanced Enzyme Tech P/B Ratio 1.95
EPS (TTM) ₹15.08
Dividend Yield 1.88%
Debt to Equity 0.02
ADVENZYMES 52 Week High ₹392.10
Advanced Enzyme Tech 52 Week Low ₹255.30
Operating Margin 31.00%
Profit Margin 21.33%
ADVENZYMES Revenue (TTM) ₹211.00
EBITDA ₹71.00
Net Income ₹45.00
Total Assets ₹1,839.00
Total Equity ₹1,683.00

Advanced Enzyme Tech Share Price Chart

Track the current stock price of Advanced Enzyme Tech with an interactive chart. Analyse ADVENZYMES share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Advanced Enzyme Tech stock quote in one place.

The quote of ₹272.40 sits between the 52-week low of ₹255.30 and the 52-week high of ₹392.10, and the latest session moved -0.67% from the previous close.

Advanced Enzyme Tech Company Profile - Fundamental Screener

Screen Advanced Enzyme Tech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ADVENZYMES shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Biotechnology industry, and it trades under ISIN INE837H01020.

Company Details

Classification

Sector Healthcare
Industry Biotechnology
Sub-Sector Biotechnology
Segment E

Identifiers and Leadership

ISIN INE837H01020

Advanced Enzyme Tech Balance Sheet Screener

Screen ADVENZYMES balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹1,839, up from ₹1,621 in 2025.

Latest statistics put total assets at ₹1,839 and shareholder funds at ₹1,683, with a leverage ratio of 0.02.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 1,839 1,621 1,536 1,422 1,268 1,153 979 811 732 589
Current Assets 1,044 880 810 722 604 516 376 282 211 138
Fixed Assets 692 679 650 649 619 601 563 496 491 421

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 49 56 58 60 67 54 52 41 51 42
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1,683 1,469 1,371 1,284 1,140 1,031 867 705 582 485
Share Capital 22 22 22 22 22 22 22 22 22 22
Reserves & Surplus 1,609 1,399 1,302 1,213 1,066 948 817 657 537 442

Advanced Enzyme Tech Income Statement Screener - Profit & Revenue Analysis

Screen Advanced Enzyme Tech income statement and profit fundamentals. Analyze ADVENZYMES quarterly results. Advanced Enzyme Tech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹211 and net profit was ₹45, equal to earnings per unit of ₹3.84, at an operating margin of 31%.

In that period expenses were ₹140, interest cost ₹1 and tax ₹15. The next period listed, 2026-Jun, shows revenue of ₹203 and net profit of ₹39.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar

Revenue and Expenses

Revenue 211 203 176 195 195 192 167 162 156 177 150 154 164 175 135
Expenses 140 139 122 130 125 123 118 103 104 114 99 103 107 107 91

Operating Costs and Margins

EBITDA 71 64 54 65 70 69 50 58 52 63 51 51 57 68 44
Operating Profit % 31.00% 27.00% 27.00% 30.00% 33.00% 29.00% 26.00% 33.00% 29.00% 33.00% 29.00% 30.00% 33.00% 33.00% 31.00%
Depreciation 10 10 10 10 10 10 9 9 9 9 8 9 9 9 9
Interest 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1

Profit and Earnings

Profit Before Tax 60 54 44 55 60 58 40 49 42 53 42 41 48 59 34
Tax 15 15 17 15 15 15 10 14 9 14 10 12 13 16 9
Net Profit 45 39 27 40 45 43 30 35 33 39 32 29 35 43 25
EPS 3.84 3.31 2.37 3.57 3.87 3.80 2.53 3.05 2.94 3.36 2.87 2.58 3.08 3.74 2.19

Advanced Enzyme Tech Cash Flow Screener - Liquidity Fundamentals

Screen ADVENZYMES cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹157, and net cash flow was an inflow of ₹15.

Over the same period, investing activities used ₹72 and financing activities used ₹70.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 157 143 141 140 122 163 141 129 116 107
Investing Activities -72 -90 -65 -286 2 -27 -43 -124 -60 -60

Financing and Net Cash

Financing Activities -70 -73 -59 -26 -49 -26 -39 -43 -2 -65
Net Cash Flow 15 -20 17 -171 75 109 60 -38 54 -18

Advanced Enzyme Tech Shareholding Pattern Screener

See Advanced Enzyme Tech shareholding pattern with promoter, FII, and DII holdings. Check Advanced Enzyme Tech promoter holding and ownership changes for ADVENZYMES on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 43.26%, foreign institutions 25.49%, domestic institutions 5.41% and the public 17.57%, spread across 66,193 shareholders.

The shareholder count was 66,193 in 2026-Mar, compared with 63,599 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 43.26% 43.24% 43.08% 43.08% 43.07% 43.04% 43.49% 43.02%

Institutional Investors

FII Holding 25.49% 26.71% 11.90% 23.46% 25.41% 25.86% 23.01% 12.03%
DII Holding 5.41% 4.78% 8.19% 8.45% 6.41% 5.51% 7.56% 8.08%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 17.57% 16.94% 16.68% 16.92% 16.95% 17.44% 15.43% 16.42%
Other Holding 8.26% 8.33% 20.16% 8.10% 8.15% 8.15% 10.51% 20.45%
Shareholder Count 66,193 63,599 65,322 67,589 69,637 68,051 68,640 65,222

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Advanced Enzyme Tech. Advanced Enzyme Tech dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹5.35 per unit for 2026-March, a yield of 1.89%, compared with ₹5.20 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹5.35, ₹5.20 and ₹5.10 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹5.35 1.89%
2025-March ₹5.20 2.04%
2024-March ₹5.10 1.83%
2023-March ₹1.00 0.29%
2022-March ₹1.00 0.42%
2021-March ₹0.90 0.32%
2020-March ₹0.60 0.17%
2019-March ₹0.60 0.42%
2018-March ₹0.50 0.27%
2017-March ₹0.40 0.19%

Advanced Enzyme Tech Stock Index Membership - Nifty & Sensex

See which indices include Advanced Enzyme Tech stock. Check ADVENZYMES index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 5 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT

Advanced Enzyme Tech Market Events Screener - Corporate Actions

Get Advanced Enzyme Tech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Advanced Enzyme Tech stock events that may affect ADVENZYMES share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 8, 2026, with a record date of August 8, 2026.

It is followed by Annual General Meeting dated July 31, 2026 and Dividend dated July 24, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-08 2026-08-08 Quarterly Result Announcement NA 2.95%
2026-07-31 2026-07-31 Annual General Meeting NA -2.49%
2026-07-24 2026-07-24 Dividend ₹ 1.35 /share -12.04%
2026-05-09 2026-05-09 Quarterly Result Announcement NA 2.67%
2026-01-31 2026-01-31 Quarterly Result Announcement NA 9.05%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -3.24%
2025-08-02 2025-08-02 Quarterly Result Announcement NA 9.08%
2025-07-30 2025-07-30 Annual General Meeting NA 17.48%
2025-07-23 2025-07-23 Dividend ₹ 1.20 /share 14.47%
2025-05-16 2025-05-17 Dividend ₹ 4.00 /share -2.19%
2025-05-13 2025-05-13 Quarterly Result Announcement NA 3.73%
2025-02-08 2025-02-08 Quarterly Result Announcement NA 0.59%
2024-11-09 2024-11-09 Quarterly Result Announcement NA 8.58%
2024-07-25 2024-07-25 Annual General Meeting NA -0.83%
2024-07-18 2024-07-18 Dividend ₹ 1.10 /share -4.39%

Advanced Enzyme Tech Competitors Screener - Peer Stocks Comparison

Screen ADVENZYMES competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 6 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Anthem Biosciences 48,621 83.28 2,280 18.12% 592 36.45
Advanced Enzyme Tech 3,140 18.50 781 16.51% 174 35.27
CCME Global 208 -254.68 4 % 0 55.93
Vivo Bio Tech 37 -12.79 54 4.47% -2 34.06
Shree Ganesh Bio-Tech 19 -46.00 6 -73.77% 0 32.55
Genomic Valley Biotech 9 414.29 0 -66.25% 0 47.00

Advanced Enzyme Tech Company Announcements - News & Reports Screener

Screen ADVENZYMES latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated October 4, 2026 and October 2, 2026.

Date Update Actions
Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-10-04 Closure of Trading Window -
2026-10-02 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-10-01 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-30 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-29 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-28 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-25 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-17 Disclosure Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (As Amended) -
2026-09-17 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-16 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-15 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-11 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-10 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-10 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-09 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-08 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-08 Corporate Action-Updates on Buy back -
2026-09-07 Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares -
2026-09-05 Disclosure Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (As Amended) -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹272.40, within a 52-week range of ₹255.30 to ₹392.10. The P/E ratio is 18.50 and the P/B ratio is 1.95, with earnings per unit of ₹15.08. Market capitalisation stands at ₹3,139.81 Cr and the dividend yield is 1.88%. The company operates in the Healthcare sector, in the Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.